Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Guillermo Garcia-Manero, Vincent Ribrag, Yayan Zhang, Mohammed Farooqui, Patricia Marinello & B. Douglas Smith. (2022) Pembrolizumab for myelodysplastic syndromes after failure of hypomethylating agents in the phase 1b KEYNOTE-013 study. Leukemia & Lymphoma 63:7, pages 1660-1668.
Read now
Read now
Amer M. Zeidan, Xin Hu, Weiwei Zhu, Maximilian Stahl, Rong Wang, Scott F. Huntington, Smith Giri, Jan Philipp Bewersdorf, Nikolai A. Podoltsev, Steven D. Gore, Xiaomei Ma & Amy J. Davidoff. (2020) Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents. Leukemia & Lymphoma 61:2, pages 397-408.
Read now
Read now
Rory M. Shallis & Amer M. Zeidan. (2018) Lenalidomide in non-deletion 5q lower-risk myelodysplastic syndromes: a glass quarter full or three quarters empty?. Leukemia & Lymphoma 59:9, pages 2015-2017.
Read now
Read now
Sarah Parisi, Stefano Ratti, Sara Mongiorgi, Pann-Ghill Suh, Lucia Manzoli, James A. McCubrey, Lucio Cocco, Matilde Y. Follo & Carlo Finelli. (2018) Current therapy and new drugs: a road to personalized treatment of myelodysplastic syndromes. Expert Review of Precision Medicine and Drug Development 3:1, pages 23-31.
Read now
Read now
Maximilian Stahl & Amer M. Zeidan. (2017) Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends. Expert Review of Hematology 10:4, pages 345-364.
Read now
Read now
Articles from other publishers (9)
Teng Fan, Xiaomin Feng, Asumi Yokota, Weiyi Liu, Yuting Tang, Xiaomei Yan, Haiyan Xiao, Yue Wang, Zhongyang Deng, Pan Zhao, Mingjing Wang, Hongzhi Wang, Rou Ma, Xiaomei Hu & Gang Huang. (2021) Arsenic Dispensing Powder Promotes Erythropoiesis in Myelodysplastic Syndromes via Downregulation of HIF1A and Upregulation of GATA Factors. The American Journal of Chinese Medicine 49:02, pages 461-485.
Crossref
Crossref
Amer M. Zeidan, Smith Giri, Michelle DeVeaux, Samir K. Ballas & Vu H. Duong. (2018) Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes. Annals of Hematology 98:2, pages 339-350.
Crossref
Crossref
Rory M. Shallis, Rami Ahmad & Amer M. Zeidan. (2018) The genetic and molecular pathogenesis of myelodysplastic syndromes. European Journal of Haematology 101:3, pages 260-271.
Crossref
Crossref
Amer M. Zeidan, Maximilian Stahl, Mikkael A. Sekeres, David P. Steensma, Rami S. Komrokji & Steven D. Gore. (2017) A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials. Cancer 123:19, pages 3662-3672.
Crossref
Crossref
Maximilian Stahl, Benjamin Y. Lu, Tae Kon Kim & Amer M. Zeidan. (2017) Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?. Targeted Oncology 12:4, pages 413-447.
Crossref
Crossref
Olumide Gbolahan, Amer Zeidan, Maximilian Stahl, Mohammad Abu Zaid, Sherif Farag, Sophie Paczesny & Heiko Konig. (2017) Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment. International Journal of Molecular Sciences 18:8, pages 1660.
Crossref
Crossref
A M Zeidan, N Al Ali, J Barnard, E Padron, J E Lancet, M A Sekeres, D P Steensma, A DeZern, G Roboz, E Jabbour, G Garcia-Manero, A List & R Komrokji. (2017) Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium. Leukemia 31:6, pages 1391-1397.
Crossref
Crossref
Jason Weed, Christine Ko, Maximilian Stahl, Melissa Much, David Witt, Amer M. Zeidan & Jonathan Leventhal. (2017) Reactive granulomatous dermatitis presenting as subcutaneous nodules and cords in a patient with advanced myelodysplastic syndrome. Annals of Hematology 96:6, pages 1037-1039.
Crossref
Crossref
Maximilian Stahl & Amer M. Zeidan. (2017) Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications. Cancer 123:10, pages 1703-1713.
Crossref
Crossref